Qualigen Therapeutics, Inc. Received Extension from Nasdaq Hearings Panel
September 20, 2024 09:00 ET
|
Qualigen Therapeutics, Inc.
CARLSBAD, Calif., Sept. 20, 2024 (GLOBE NEWSWIRE) -- Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (the “Company”) today announced that on September 11, 2024, the Company received a notice from Nasdaq...
Connexa Announces Receipt of Nasdaq Delisting Notice
February 21, 2023 08:30 ET
|
Connexa Sports Technologies Inc.
Baltimore, Feb. 21, 2023 (GLOBE NEWSWIRE) -- Connexa Sports Technologies Inc. (NASDAQ: CNXA) (www.connexasports.com) (the “Company”) announced that it received a letter from The Nasdaq Stock...
Jensyn Acquisition Corp. Receives Nasdaq Delisting Notice
March 08, 2019 17:00 ET
|
Jensyn Acquisition Corp.
Freehold, N.J., March 08, 2019 (GLOBE NEWSWIRE) -- Jensyn Acquisition Corp. (NASDAQ:JSYN) (“Jensyn Acquisition” or the “Company”), a company formed for the purpose of entering into a merger, share...